Nancy Wysenski Cytokinetics Inc (CYTK) insider trading activity

CYTK Quotes by TradingView

Nancy Wysenski is Director of CYTOKINETICS INC. Currently has a direct ownership of 23,115 shares of CYTK, which is worth approximately $1.06 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 127 shares (Common Stock) at a price of $48.93 per share, resulting in proceeds of $6,214. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.1K
0.55% 3M change
34.73% 12M change
Total Value Held $1.06 Million

Nancy Wysenski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
BUY
Grant, award, or other acquisition
$6,214 $48.93 p/Share
127 Added 0.55%
23,115 Common Stock
Oct 01 2024
BUY
Grant, award, or other acquisition
$6,206 $52.6 p/Share
118 Added 0.51%
22,988 Common Stock
Jul 01 2024
BUY
Grant, award, or other acquisition
-
114 Added 0.5%
22,870 Common Stock
May 15 2024
BUY
Grant, award, or other acquisition
-
5,600 Added 19.75%
22,756 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
$6,224 $84.12 p/Share
74 Added 0.43%
17,156 Common Stock
Oct 02 2023
BUY
Grant, award, or other acquisition
$6,245 $27.88 p/Share
224 Added 1.29%
17,082 Common Stock
Jul 03 2023
BUY
Grant, award, or other acquisition
$6,238 $33.36 p/Share
187 Added 1.1%
16,858 Common Stock
May 10 2023
BUY
Grant, award, or other acquisition
-
5,000 Added 23.07%
16,671 Common Stock
Apr 03 2023
BUY
Grant, award, or other acquisition
$5,618 $37.71 p/Share
149 Added 1.26%
11,671 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
$5,588 $44.35 p/Share
126 Added 1.08%
11,522 Common Stock
Oct 03 2022
BUY
Grant, award, or other acquisition
$5,622 $51.11 p/Share
110 Added 0.96%
11,396 Common Stock
Jul 01 2022
BUY
Grant, award, or other acquisition
$5,617 $41.0 p/Share
137 Added 1.2%
11,286 Common Stock
May 10 2022
BUY
Grant, award, or other acquisition
-
5,000 Added 30.96%
11,149 Common Stock
Apr 01 2022
BUY
Grant, award, or other acquisition
$5,603 $38.38 p/Share
146 Added 2.32%
6,149 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
$5,612 $46.0 p/Share
122 Added 1.99%
6,003 Common Stock
Oct 01 2021
BUY
Grant, award, or other acquisition
$5,621 $36.74 p/Share
153 Added 2.54%
5,881 Common Stock
Jul 07 2021
BUY
Grant, award, or other acquisition
$613 $19.77 p/Share
31 Added 0.54%
5,728 Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
$4,993 $20.98 p/Share
238 Added 4.01%
5,697 Common Stock
May 12 2021
BUY
Grant, award, or other acquisition
-
5,000 Added 47.81%
5,459 Common Stock
Apr 01 2021
BUY
Grant, award, or other acquisition
$4,986 $24.44 p/Share
204 Added 30.77%
459 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
$4,988 $19.56 p/Share
255 Added 50.0%
255 Common Stock

Also insider at

ALKS
Alkermes plc. Healthcare
Director
PRVB
Provention Bio, Inc. Healthcare
Director
NW

Nancy Wysenski

Director
Dublin,

Track Institutional and Insider Activities on CYTK

Follow CYTOKINETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

News

Receive news related to CYTOKINETICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYTK